Healthcare Services

Global Nocturia Market Forecast Highlighting Expansion And Competitive Dynamics

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Value Expansion Is Expected For The Nocturia Market Over The Forecast Period?

The nocturia market size has demonstrated significant expansion in recent years. It is anticipated to increase from $3.1 billion in 2025 to $3.35 billion by 2026, achieving a compound annual growth rate (CAGR) of 8.0%. The growth observed during the historical period is primarily a result of the expanding aging population, a higher incidence of benign prostatic hyperplasia, the rising prevalence of urinary tract infections, the extensive use of diuretic medications, and limited early diagnostic awareness.

The nocturia market size is anticipated to experience robust expansion in the coming years. It is projected to reach $4.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period can be attributed to the escalating demand for personalized treatment, the proliferation of home care therapies, rising healthcare expenditure, a heightened emphasis on sleep quality management, and enhanced access to urology specialists. Furthermore, major trends throughout this period include an increasing geriatric population and age-related urological disorders, the growing prevalence of diabetes and metabolic disorders, greater awareness and diagnosis of lower urinary tract symptoms, a transition towards combination drug therapies, and the expansion of home-based nocturia management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21232&type=smp

Which Major Factors Are Contributing To The Development Of The Nocturia Market?

The increasing occurrence of cardiovascular diseases is anticipated to boost the expansion of the nocturia market in the future. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as heart disease, stroke, and hypertension. Their widespread presence is linked to factors including an aging global populace, inactive lifestyles, poor dietary habits, smoking, heavy alcohol intake, obesity, high blood pressure, elevated cholesterol levels, diabetes, and genetic susceptibility. Individuals suffering from cardiovascular diseases frequently exhibit nocturia as a symptom, thereby generating increased demand for diagnostic and therapeutic options. With the global surge in cardiovascular conditions, driven by aging demographics and unhealthy living, the necessity for robust nocturia management will intensify. To illustrate, the British Heart Foundation, a UK-based charity, reported in September 2025 that over 7.6 million people in the UK—comprising more than 4 million men and over 3.6 million women—are currently affected by cardiovascular disease. Forecasts suggest that, fueled by an aging population and enhanced survival rates, this figure could increase by approximately 1 million by 2030 and by about 2 million by 2040. Consequently, the increasing incidence of cardiovascular diseases is serving as a primary catalyst for the expansion of the nocturia market.

Which Segment Groups Define The Nocturia Market Landscape?

The nocturia market covered in this report is segmented –

1) By Drug: Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs

2) By Indication: Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria

3) By Causes: Urological Infection, Tumor Of The Bladder, Diuretic Medications, Regular Alcohol Or Coffee, Liver Infection, Diabetes, Pregnancy, Other Causes

4) By End User: Hospitals, Home Care, Clinics

Subsegments:

1) By Anticholinergic Drugs: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine

2) By Desmopressin: Intranasal Desmopressin, Oral Desmopressin

3) By Antibiotics: Nitrofurantoin, Trimethoprim, Fosfomycin

4) By Antispasmodic: Hyoscine Butylbromide, Flavoxate

5) By Other Drugs: Alpha-Blockers, Beta-3 Agonists

Which Trends Are Influencing The Expansion Of The Nocturia Market?

Major companies within the night blindness treatment market are actively developing innovative genetic therapies to address the underlying genetic mutations responsible for enhancing treatment efficacy and improving patient outcomes. Genetic therapies aid in treating night blindness by targeting and repairing specific genetic mutations that impact retinal function, potentially restoring vision for individuals with inherited retinal disorders such as retinitis pigmentosa. For instance, in August 2023, HuidaGene Therapeutics, a US-based clinical-stage biotechnology company, introduced HG004, a gene therapy tailored to treat inherited retinal diseases like Leber’s congenital amaurosis. This therapy has demonstrated superiority over existing treatments in preclinical studies, aiming to restore retinal function and alleviate night blindness and other conditions associated with RPE65-induced impairments.

Who Are The Major Companies Operating In The Nocturia Market?

Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc

Access The Complete Nocturia Market Report:

https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report

Which Region Stands As The Largest Contributor To The Nocturia Market?

North America was the largest region in the nocturia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Nocturia Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21232&type=smp

Browse Through More Reports Similar to the Global Nocturia Market 2026, By The Business Research Company

Retinal Disorder Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Night Vision Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/night-vision-devices-global-market-report

Optic Nerve Disorders Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795